(Q40742216)

English

Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells

scientific article published on January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells (English)

1 reference

Europe PubMed Central

23 September 2017

author name string

Francis J Burrows

1

1 reference

Europe PubMed Central

23 September 2017

Martin Gore

2

1 reference

Europe PubMed Central

23 September 2017

W Russell Smiley

3

1 reference

Europe PubMed Central

23 September 2017

Martha Y Kanemitsu

4

1 reference

Europe PubMed Central

23 September 2017

Douglas J Jolly

5

1 reference

Europe PubMed Central

23 September 2017

Susana B Read

6

1 reference

Europe PubMed Central

23 September 2017

Thomas Nicholas

7

1 reference

Europe PubMed Central

23 September 2017

Carol A Kruse

8

1 reference

Europe PubMed Central

23 September 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

23 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

23 September 2017

9

1 reference

Europe PubMed Central

23 September 2017

87-95

1 reference

Europe PubMed Central

23 September 2017

1

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700401

0 references

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Bystander tumoricidal effect in the treatment of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Immune system in suicide-gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

21 January 2018

Potentiation of the bystander effect by immunization combined with suicide gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700401

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700401

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40742216&oldid=1906321655"